Questions discussed in this category
From a geriatrics harm-reduction standpoint, can we recommend any particulars regarding dosing or selection of therapies when used as a last resort?
What factors might drive decisions for different SSRIs and/or doses?
Would you consider adding a second medication versus uptitrating the original SSRI?
253212646525316253092530725618253122531024564
Papers discussed in this category
Archives of general psychiatry, 2008 Dec
Current nutrition reports, 2022 Sep 13
Journal of pain and symptom management, 2002-05
Annals of internal medicine, 2025 Sep 30
British journal of clinical pharmacology, 2023 Jun 13
Journal of the American Geriatrics Society, 2013 Sep
The Cochrane database of systematic reviews, 2006-07-19
Psychiatry and clinical neurosciences, 2010 Feb 01
Basic & clinical pharmacology & toxicology, 2023 Jun 20
Ochsner journal, 2013 Winter
The American journal of psychiatry, 2016-05-01
The American journal of psychiatry, 2016-05-01
JAMA, 2014 Feb 19
Frontiers in aging neuroscience, 2023 Mar 03
Journal of Alzheimer's disease : JAD, 2020
Journal of the American Geriatrics Society, 2025 Apr 28
Journal of the American Geriatrics Society, 2016 Mar 23
The Cochrane database of systematic reviews, 2018 Jun 18
JAMA, 2011-09-28
The Cochrane database of systematic reviews, 2014-03-21
Translational psychiatry, 2022 Apr 01
Journal of sleep research, 2020 Dec 02
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2016 Jan 27
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022 Dec 01
CNS drugs, 2024 Aug 09